Page 124 - 80_03
P. 124
A.I.
Fraguas--Sánchez
&
al.
37.
Matias,
I.;
Bisogno,
T.;
Di
Marzo,
V.
Endogenous
cannabinoids
in
the
brain
and
peripheral
tissues:
regulation
of
their
levels
and
control
of
food
intake.
Int
J
Obes
(Lond),
30
(Suppl
1)
S7--S12
(2006).
38.
Brown,
T.
T.;
Dobs,
A.
S.
Endocrine
effects
of
marijuana.
J
Clin
Pharmaco,
92
(11
suppl),
90S--96S
(2002).
39.
Battista,
N.;
Rapino;
C.;
Di
Tommaso,
M.;
Bari,
M.;
Pasquariello,
N.¸
Maccarrone,
M.
Regulation
of
male
fertility
by
the
endocannabinoid
system.
Mol
Cell
Endocrinol,
286
(1--2
suppl
1),
17S--23S
(2008).
40.
Cota,
D.
The
role
of
the
endocannabinoid
system
in
the
regulation
of
hypothalamic--
pituitary--adrenal
axis
activity.
J
Neuroendocrinol,
20
(suppl
1):35--38
(2008).
41.
Sun,
Y.;
Alexander,
S.
P.;
Garle,
M.
J.;
Gibson,
C.
L.;
Hewitt,
K.;
Murphy,
S.
P.;
Kendall,
D.
A.;
Bennett,
A.
J.
Cannabinoid
activation
of
PPAR
alpha;
a
novel
neuroprotective
mechanism.
Br
J
Pharmacol,
152
(5),
734--743
(2007).
42.
O'Sullivan,
S.
E.
Cannabinoids
go
nuclear:
evidence
for
activation
of
peroxisome
proliferator--activated
receptors.
Br
J
Pharmacol,
152
(5),
576--582
(2007).
43.
Duran,
M.;
Laporte,
J.
R.;
Capellà,
D.
Novedades
sobre
las
potencialidades
terapéuticas
del
Cannabis
y
el
sistema
cannabinoide.
Med
Clin
(Barc),
122
(10),
390--398
(2004).
44.
Lunn,
C.
A.;
Fine,
J.
S.;
Rojas--Triana,
A.;
Jackson,
J.
V.;
Fan,
X.;
Kung,
T.T.;
Gonsiorek,
W.;
Schwarz,
M.
A.,
Lavey,
B.;
Kozlowski,
J.
A.;
Narula,
S.
K.;
Lundell,
D.
J.;
Hipkin,
R.
W.;
Bober,
L.
A.
A
novel
cannabinoid
peripheral
cannabinoid
receptorselective
inverse
agonist
blocks
leukocyte
recruitment
in
vivo.
J
Pharmacol
Exp
Ther
316
(2),
780--788
(2006).
45.
Howlett,
A.C.;
Barth,
F.;
Bonner,
T.I.;
Cabral,
G.;
Casellas,
P.;
Devane,
W.
A.;
Felder,
C.
C.;
Herkenham,
M.;
Mackie,
B.
R.;
Mechoulam,
R.;
Pertwee,
G.
nternational
Union
of
Pharmacology
XXVII.
Classification
of
cannabinoid
receptors.
Pharmacol
Rev;
54:161--202
(2002).
46.
Pertwee,
R.
G.
Ligands
that
target
cannabinoid
receptors
in
the
brain:
from
THC
to
anandamide
and
beyond.
Addict
Biol;
13
(2),
147--159
(2008).
47.
Sagredo,
O.;
García--Arencibia,
M.;
De
Lago,
E.;
Finetti,
S.;
Decio,
A.;
Fernández--Ruiz,
J.
Cannabinoids
and
neuroprotection
in
basal
ganglia
disorders.
Mol
Neurobiol,
36
(1),
82--91
(2007).
48.
Pacher,
P.;
Kunos,
G.
Modulating
the
endocannabinoid
system
in
human
health
and
disease--
--successes
and
failures.
FEBS
J,
280
(9):1918--1943
(2013).
49
Booz,
G.
W.
Cannabidiol
as
an
emergent
therapeutic
strategy
for
lessening
the
impact
of
inflammation
on
oxidative
stress.
Free
Radic
Biol
Med,
51
(5),
1054--1061
(2011).
50.
Kogan,
N.
M.;
Mechoulam,
R.
Cannabinoids
in
health
and
disease.
Dialogues
Clin
Neurosci.
9
(4),
413--430
(2007).
51.
Fernández--Ruiz,
J.;
Romero,
J.;
Velasco,
G.;
Tolón,
R.
M.;
Ramos,
J.
A.;
Guzmán,
M.
Cannabinoid
CB2
receptor:
a
new
target
for
controlling
neural
cell
survival?.
Trends
Pharmacol
Sci;
28
(1),
39--45
(2007).
52.
Croxford,
J.
L.;
Yamamura,
T.
Cannabinoids
and
the
immune
system:
potential
for
the
treatment
of
inflammatory
diseases?.
J
Neuroimmunol,
166
(1--2),
3--18
(2005).
53.
Baker,
D.;
Jackson,
S.
J.;
Pryce,
G.
Cannabinoid
control
of
neuroinflammation
related
to
multiple
sclerosis.
Br
J
Pharmacol,
152
(5),
649--654
(2007).
54.
Baker,
D.;
Pryce,
G.
The
endocannabinoid
system
and
multiple
sclerosis.
Curr
Pharm
Des,
14
(23),
2326--2336
(2008).
54.
Fernández--Ruiz,
J.;
Romero,
J.;
Velasco,
G.;
Tolón,
R.
M.;
Ramos,
J.
A.;
Guzmán,
M.
Cannabinoid
CB2
receptor:
a
new
target
for
controlling
neural
cell
survival?.
Trends
Pharmacol
Sci;
28
(1),
39--45
(2007).
55.
Ryan,
D.;
Drysdale,
A.
J.;
Lafourcade,
C.;
Pertwee,
R.
G.;
Platt,
B.
Cannabidiol
targets
mitochondria
to
regulate
intracellular
Ca2+
levels.
J
Neurosci,
29
(7)
2053--2063
(2009).
56.
Croxford,
J.
L.;
Yamamura,
T.
Cannabinoids
and
the
immune
system:
potential
for
the
treatment
of
inflammatory
diseases?.
J
Neuroimmunol,
166
(1--2),
3--18
(2005).
56.
Saito,
V.
M.;
Rezende,
R.
M.;
Teixeira,
A.
L.
Cannabinoid
modulation
of
neuroinflammatory
disorders.
Curr
Neuropharmacol,
10
(2),
159--66
(2012).
57.
Aso,
E.;
Ferrer,
I.
Cannabinoids
for
treatment
of
Alzheimer's
disease:
moving
toward
the
clinic.
Front
Pharmacol,
5,
1--11
(2014).
58.
Ruiz--Valdepeñas,
L.;
Benito,
C.;
Tolón,
R.
M.;
Martínez
Orgado,
J.
A.;
Romero,
J.
The
endocannabinoid
system
and
amyloid--related
diseases.
Exp
Neurol,
224
(1),
66--73
(2010).
576
